Amgen Inc (AMGN)
319.22
-0.94
(-0.29%)
USD |
NASDAQ |
Nov 01, 16:00
317.56
-1.66
(-0.52%)
After-Hours: 20:00
Amgen Revenue (Quarterly): 8.503B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.503B |
| June 30, 2024 | 8.388B |
| March 31, 2024 | 7.447B |
| December 31, 2023 | 8.196B |
| September 30, 2023 | 6.903B |
| June 30, 2023 | 6.986B |
| March 31, 2023 | 6.105B |
| December 31, 2022 | 6.839B |
| September 30, 2022 | 6.652B |
| June 30, 2022 | 6.594B |
| March 31, 2022 | 6.238B |
| December 31, 2021 | 6.846B |
| September 30, 2021 | 6.706B |
| June 30, 2021 | 6.526B |
| March 31, 2021 | 5.901B |
| December 31, 2020 | 6.634B |
| September 30, 2020 | 6.423B |
| June 30, 2020 | 6.206B |
| March 31, 2020 | 6.161B |
| December 31, 2019 | 6.197B |
| September 30, 2019 | 5.737B |
| June 30, 2019 | 5.871B |
| March 31, 2019 | 5.557B |
| December 31, 2018 | 6.23B |
| September 30, 2018 | 5.904B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.059B |
| March 31, 2018 | 5.554B |
| December 31, 2017 | 5.802B |
| September 30, 2017 | 5.773B |
| June 30, 2017 | 5.81B |
| March 31, 2017 | 5.464B |
| December 31, 2016 | 5.965B |
| September 30, 2016 | 5.811B |
| June 30, 2016 | 5.688B |
| March 31, 2016 | 5.527B |
| December 31, 2015 | 5.536B |
| September 30, 2015 | 5.723B |
| June 30, 2015 | 5.37B |
| March 31, 2015 | 5.033B |
| December 31, 2014 | 5.331B |
| September 30, 2014 | 5.031B |
| June 30, 2014 | 5.18B |
| March 31, 2014 | 4.521B |
| December 31, 2013 | 5.011B |
| September 30, 2013 | 4.748B |
| June 30, 2013 | 4.679B |
| March 31, 2013 | 4.238B |
| December 31, 2012 | 4.421B |
| September 30, 2012 | 4.319B |
| June 30, 2012 | 4.477B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.901B
Minimum
Mar 2021
8.503B
Maximum
Sep 2024
6.823B
Average
6.643B
Median
Revenue (Quarterly) Benchmarks
| Johnson & Johnson | 22.47B |
| Eli Lilly and Co | 11.44B |
| Merck & Co Inc | 16.66B |
| Regeneron Pharmaceuticals Inc | 3.721B |
| Viking Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.83B |
| Total Expenses (Quarterly) | 6.456B |
| EPS Diluted (Quarterly) | 5.22 |
| Enterprise Value | 222.98B |
| Gross Profit Margin (Quarterly) | 61.07% |
| Profit Margin (Quarterly) | 33.28% |
| Earnings Yield | 2.45% |
| Operating Earnings Yield | 3.61% |
| Normalized Earnings Yield | 2.447 |